The landscape of the international pharmaceutical industry is undergoing a seismic shift as Angelini Pharma executes a definitive agreement to acquire Catalyst Pharmaceuticals in an all-cash transaction valued at approximately 4.1 billion dollars. This monumental deal provides Angelini with an
The legal landscape regarding reproductive healthcare in Maryland has reached a critical juncture as the state prepares for a definitive U.S. Supreme Court ruling on the accessibility of mifepristone. While Maryland has spent the last few years fortifying its status as a sanctuary for reproductive
For millions of individuals living with the daily reality of Sjögren’s disease, the simple act of blinking or swallowing can become an agonizing reminder of a systemic health struggle that lacks a definitive cure. This chronic autoimmune condition, characterized by the body’s immune system
CVS Health’s recent upward revision of its financial expectations marks a significant turning point for a healthcare giant that spent much of the past two years navigating leadership transitions and volatile market conditions. Following a stellar first-quarter performance that exceeded Wall Street
The promise of precision medicine rests on the ability to tailor therapies to an individual’s unique genetic profile, yet the systems designed to validate and deliver these treatments remain tethered to an obsolete framework. While the molecular breakthroughs of the current decade allow for
The landscape of reproductive healthcare in the United States faces another profound shift as the Supreme Court, through a decisive order issued by Justice Samuel Alito, temporarily reinstates broad access to the primary pharmaceutical option for terminating pregnancies. This specific intervention
